The newly published report by IMARC Group has recently released a report titled “Emphysema Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)” that presents a comprehensive assessment of the emphysema market. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market size, and growth trends. Furthermore, the report offers an analysis of competitors, regional markets, and recent advancements in the global market. It also sheds light on crucial segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the emphysema market.
Emphysema refers to a lower respiratory tract disorder in which the air sacs (alveoli) in the lungs are destroyed, resulting in decreased oxygen supply in the bloodstream. Some of the symptoms include rapid breathing, shortness of breath, coughing (with or without sputum), tightness in the chest, wheezing, etc. Individuals who have this condition may also experience sleep problems, fatigue, depression, weight loss, anxiety, cold or flu infections, etc. The diagnosis typically involves a physical examination and blood and pulmonary function tests. Several imaging procedures, including chest X-rays and computed tomography (CT) scans, are employed to visualize the lungs and determine the extent of the damage.
Request a Free Sample Report: https://www.imarcgroup.com/emphysema-market/requestsample
Market Trend:
The elevating prevalence of respiratory infections owing to high levels of air pollution, tobacco smoking, and exposure to dust and chemical fumes is primarily augmenting the emphysema market. In addition to this, the growing incidences of genetic disorders on account of inherited gene mutations and DNA abnormalities are further propelling the market growth. Moreover, the increasing usage of effective medications, including anti-inflammatories, bronchodilators, and corticosteroids, to treat emphysema by relaxing airway muscles and minimizing swelling is acting as another significant growth-inducing factor. Apart from this, the rising adoption of lung volume reduction surgery, which involves the removal of small wedges of damaged lung tissue to enhance the function of the remaining tissue, is also fueling the market growth. Furthermore, continuous technological advancements, including the development of new inhalation devices that improve patient adherence to therapy, are offering lucrative growth opportunities to the market. Besides this, the increasing utilization of targeted biologics, such as monoclonal antibodies, for reducing disease exacerbation and targeting eosinophilic inflammation is projected to cater to the growth of the emphysema market in the coming years.
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the emphysema market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the emphysema market
- Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/emphysema-market
Key Questions Answered in this Report:
- How has the emphysema market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the emphysema market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the emphysema market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
Browse the Latest Research Report:
Acute Intermittent Porphyria Market Report 2023-2033
Acute Lymphoblastic Leukemia Market Report 2023-2033
Acute Lung Injury Market Share, Future Forecast (2023-2033)
Chronic Heart Failure Market Size, Future Forecast (2023-2033)
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
